FFA
OLMA icon

Farther Finance Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Farther Finance Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25K Hold
180
– – ﹤0.01% 5132
2026
Q1 		$2.72K Hold
180
– – ﹤0.01% 4769
2025
Q4 		$4.5K Buy
180
+150
+500% +$2.67K ﹤0.01% 4369
2025
Q3 		$294 Sell
30
-6,809
-100% -$40.9K ﹤0.01% 4644
2025
Q2 		$29.1K Buy
6,839
+5,866
+603% +$26.2K ﹤0.01% 2442
2025
Q1 		$3.25K Buy
+973
New +$4.89K ﹤0.01% 3214

Other funds holding OLMA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

Farther Finance Advisors's OLMA Position: Q2 2026 in Review

Farther Finance Advisors held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 180 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #5132.

Farther Finance Advisors first reported a position in OLMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $29.1K in Q2 2025. 10 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Farther Finance Advisors held 180 shares of Olema Pharmaceuticals worth $2.25K as of Q2 2026.
  • Farther Finance Advisors left its Olema Pharmaceuticals share count unchanged in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5132 holding.
  • Farther Finance Advisors first reported a position in Olema Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Farther Finance Advisors's Olema Pharmaceuticals position peaked at $29.1K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.